{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T07:17:38Z","timestamp":1769757458187,"version":"3.49.0"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2008,11,25]],"date-time":"2008-11-25T00:00:00Z","timestamp":1227571200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0003801","type":"journal-article","created":{"date-parts":[[2008,11,25]],"date-time":"2008-11-25T00:06:00Z","timestamp":1227571560000},"page":"e3801","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":27,"title":["VHL Type 2B Mutations Retain VBC Complex Form and Function"],"prefix":"10.1371","volume":"3","author":[{"given":"Kathryn E.","family":"Hacker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline Martz","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. Kimryn","family":"Rathmell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2008,11,25]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1111\/j.1538-7836.2005.01441.x","article-title":"VHL: oxygen sensing and vasculogenesis.","volume":"3","author":"WK Rathmell","year":"2005","journal-title":"J Thromb Haemost"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1093\/hmg\/3.8.1303","article-title":"Identification of intragenic mutations in the von Hippel-Lindau disease tumour suppressor gene and correlation with disease phenotype.","volume":"3","author":"PA Crossey","year":"1994","journal-title":"Hum Mol Genet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/(SICI)1098-1004(1996)8:4<348::AID-HUMU8>3.0.CO;2-3","article-title":"Germline mutations in the Von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan.","volume":"8","author":"B Zbar","year":"1996","journal-title":"Hum Mutat"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/humu.1380050109","article-title":"Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype.","volume":"5","author":"F Chen","year":"1995","journal-title":"Human Mutation"},{"key":"ref5","first-page":"1035","article-title":"Isolated familial pheochromocytoma as a variant of von Hippel-Lindau disease.","volume":"81","author":"MM Ritter","year":"1996","journal-title":"Journal of clinical endocrinology and metabolism"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/ng1019","article-title":"Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia.","volume":"32","author":"SO Ang","year":"2002","journal-title":"Nat Genet"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1182\/blood-2002-06-1843","article-title":"Mutations in the VHL gene in sporadic apparently congenital polycythemia.","volume":"101","author":"YD Pastore","year":"2003","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"4726","DOI":"10.1158\/1078-0432.CCR-07-4921","article-title":"Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors.","volume":"14","author":"ML Nickerson","year":"2008","journal-title":"Clin Cancer Res"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1158\/0008-5472.CAN-05-3074","article-title":"Genetic and epigenetic analysis of von Hippel-Lindau (VHL) gene alterations and relationship with clinical variables in sporadic renal cancer.","volume":"66","author":"RE Banks","year":"2006","journal-title":"Cancer Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1586\/14737140.8.1.63","article-title":"VHL inactivation in renal cell carcinoma: implications for diagnosis, prognosis, and treatment.","volume":"8","author":"WK Rathmell","year":"2008","journal-title":"Expert Rev Anticancer Ther"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1042\/bj20040198","article-title":"Getting into position: the catalytic mechanisms and protein ubiquitylation.","volume":"379","author":"LA Passmore","year":"2004","journal-title":"Biochemical Society"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.1365-2443.2005.00869.x","article-title":"Multiple roles of Rbx1 in the VBC-Cul2 ubiquitin ligase complex.","volume":"10","author":"Y Megumi","year":"2005","journal-title":"Genes to Cells"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1073\/pnas.94.6.2156","article-title":"The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins.","volume":"94","author":"A Pause","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1126\/science.284.5414.657","article-title":"Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase.","volume":"284","author":"T Kamura","year":"1999","journal-title":"Science"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1126\/science.284.5413.455","article-title":"Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function.","volume":"284","author":"CE Stebbins","year":"1999","journal-title":"Science"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"10595","DOI":"10.1073\/pnas.93.20.10595","article-title":"Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein.","volume":"93","author":"O Iliopoulos","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/20459","article-title":"The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.","volume":"399","author":"PH Maxwell","year":"1999","journal-title":"Nature"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"25733","DOI":"10.1074\/jbc.M002740200","article-title":"Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein.","volume":"275","author":"ME Cockman","year":"2000","journal-title":"J Biol Chem"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"10430","DOI":"10.1073\/pnas.190332597","article-title":"Activation of HIF1alpha ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex.","volume":"97","author":"T Kamura","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/hmg\/10.10.1029","article-title":"Contrasting effects on HIF-1alpha regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease.","volume":"10","author":"SC Clifford","year":"2001","journal-title":"Hum Mol Genet"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.1128\/MCB.00282-07","article-title":"Hypoxia-inducible factor linked to differential kidney cancer risk seen with type 2A and type 2B VHL mutations.","volume":"27","author":"L Li","year":"2007","journal-title":"Mol Cell Biol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S1535-6108(02)00043-0","article-title":"Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein.","volume":"1","author":"K Kondo","year":"2002","journal-title":"Cancer Cell"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/hmg\/10.10.1019","article-title":"von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF.","volume":"10","author":"MA Hoffman","year":"2001","journal-title":"Hum Mol Genet"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/sj.onc.1209062","article-title":"Renal cell carcinoma risk in type 2 von Hippel-Lindau disease correlates with defects in pVHL stability and HIF-1alpha interactions.","volume":"25","author":"K Knauth","year":"2006","journal-title":"Oncogene"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"8595","DOI":"10.1158\/0008-5472.CAN-04-1430","article-title":"In vitro and in vivo models analyzing von Hippel-Lindau disease-specific mutations.","volume":"64","author":"WK Rathmell","year":"2004","journal-title":"Cancer Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1128\/MCB.22.6.1947-1960.2002","article-title":"Diverse effects of mutations in exon II of the von Hippel-Lindau (VHL) tumor suppressor gene on the interaction of pVHL with the cytosolic chaperonin and pVHL-dependent ubiquitin ligase activity.","volume":"22","author":"WJ Hansen","year":"2002","journal-title":"Mol Cell Biol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1126\/science.7660122","article-title":"Inhibition of transcription elongation by the VHL tumor suppressor protein.","volume":"269","author":"DR Duan","year":"1995","journal-title":"Science"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.7660130","article-title":"Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C.","volume":"269","author":"A Kibel","year":"1995","journal-title":"Science"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1128\/MCB.18.2.732","article-title":"Regulation of hypoxia-inducible mRNAs by the von Hippel-Lindau tumor suppressor protein requires binding to complexes containing elongins B\/C and Cul2.","volume":"18","author":"KM Lonergan","year":"1998","journal-title":"Mol Cell Biol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1172\/JCI8161","article-title":"Synthetic peptides define critical contacts between elongin C, elongin B, and the von Hippel-Lindau protein.","volume":"104","author":"M Ohh","year":"1999","journal-title":"J Clin Invest"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0003801","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T18:07:15Z","timestamp":1557943635000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0003801"}},"subtitle":[],"editor":[{"given":"Baohong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2008,11,25]]},"references-count":30,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2008,11,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0003801","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,25]]}}}